Cargando…

The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes

OBJECTIVE: Exenatide improves postprandial glycemic excursions in type 2 diabetes. Exenatide could benefit type 1 diabetes as well. We aimed to determine an effective and safe glucose-lowering adjuvant exenatide dose in adolescents with type 1 diabetes. RESEARCH DESIGN AND METHODS: Eight subjects co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raman, Vandana S., Mason, Kimberly J., Rodriguez, Luisa M., Hassan, Krishnavathana, Yu, Xiaoying, Bomgaars, Lisa, Heptulla, Rubina A.
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875441/ https://www.ncbi.nlm.nih.gov/pubmed/20332358 http://dx.doi.org/10.2337/dc09-1959

Ejemplares similares

Insight into hypoglycemia in pediatric type 1 diabetes mellitus
por: Lehecka, Kimberly E, et al.
Publicado: (2012)

A review of exenatide as adjunctive therapy in patients with type 2 diabetes
por: Robles, Gisela I, et al.
Publicado: (2009)

Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes
por: Odegard, Peggy Soule, et al.
Publicado: (2009)

Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis
por: Ilkowitz, Jeniece Trast, et al.
Publicado: (2016)

Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
por: Sands, Arthur T., et al.
Publicado: (2015)

Mixing Insulin Aspart With Detemir Does Not Affect Glucose Excursion in Children With Type 1 Diabetes
por: Nguyen, Thanh M., et al.
Publicado: (2010)

New technologies for diabetes: a review of the present and the future
por: Ramchandani, Neesha, et al.
Publicado: (2012)

Evaluating emergency preparedness and impact of a hurricane sandy in pediatric patients with diabetes
por: Heptulla, Rubina, et al.
Publicado: (2016)

National study of continuity clinic satisfaction in pediatric fellowship training
por: Gangat, Mariam, et al.
Publicado: (2013)

Exenatide Use in the Management of Type 2 Diabetes Mellitus
por: Kyriacou, Angelos, et al.
Publicado: (2010)

Once-Weekly Exenatide in Youth With Type 2 Diabetes
por: Tamborlane, William V., et al.
Publicado: (2022)

3199 Effect of OSAS on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
por: Underland, Lisa, et al.
Publicado: (2019)

The use of exenatide in severely burned pediatric patients
por: Mecott, Gabriel A, et al.
Publicado: (2010)

Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
por: Ji, Linong, et al.
Publicado: (2013)

Efficacy and safety of once‐weekly exenatide after switching from twice‐daily exenatide in patients with type 2 diabetes
por: Watanabe, Yuusuke, et al.
Publicado: (2019)

Efficacy and tolerability of the new autoinjected suspension of exenatide once weekly versus exenatide twice daily in patients with type 2 diabetes
por: Wysham, Carol H., et al.
Publicado: (2017)

Exenatide at mealtimes in type 1 diabetes—no MAG1C with exenatide, or with other glucagon-like peptide-1 receptor agonists
por: Doggrell, Sheila A.
Publicado: (2020)

Antithrombotic Therapy in a Prospective Trial of a Pediatric Ventricular Assist Device
por: Steiner, Marie E., et al.
Publicado: (2016)

Evolution of Exenatide as a Diabetes Therapeutic
por: Bhavsar, Sunil, et al.
Publicado: (2013)

Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes
por: Schnabel, Catherine A, et al.
Publicado: (2006)

Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes
por: Kishimoto, Miyako, et al.
Publicado: (2014)

Emerging utility of once-weekly exenatide in patients with type 2 diabetes
por: Goud, Aditya, et al.
Publicado: (2015)

Exenatide Once Weekly for Management of Type 2 Diabetes: A Review
por: Inaishi, Jun, et al.
Publicado: (2022)

Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes
por: Zhang, Yaqin, et al.
Publicado: (2021)

The Impact of Dopamine on Insulin Secretion in Healthy Controls
por: Underland, Lisa J., et al.
Publicado: (2018)

Randomized Trial of Continuous Subcutaneous Delivery of Exenatide by ITCA 650 Versus Twice-Daily Exenatide Injections in Metformin-Treated Type 2 Diabetes
por: Henry, Robert R., et al.
Publicado: (2013)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Determining Predictors of Early Response to Exenatide in Patients with Type 2 Diabetes Mellitus
por: Khan, Muhammad, et al.
Publicado: (2015)

Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus
por: Torimoto, Keiichi, et al.
Publicado: (2015)

Can exenatide flatten the post-prandial glucose curve in type 1 diabetes?
por: Boughton, Charlotte K., et al.
Publicado: (2020)

Comparison of safety and tolerability with continuous (exenatide once weekly) or intermittent (exenatide twice daily) GLP-1 receptor agonism in patients with type 2 diabetes
por: Ridge, T, et al.
Publicado: (2012)

Adjunctive therapy for glucose control in patients with type 1 diabetes
por: Harris, Kira, et al.
Publicado: (2018)

Pancreatitis Incidence in the Exenatide BID, Exenatide QW, and Exenatide QW Suspension Development Programs: Pooled Analysis of 35 Clinical Trials
por: Vetter, Marion L., et al.
Publicado: (2019)

Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice
por: Tatarkiewicz, K, et al.
Publicado: (2014)

Population pharmacokinetics of exenatide
por: Cirincione, Brenda, et al.
Publicado: (2016)

Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitus
por: Seewoodhary, Jason, et al.
Publicado: (2010)

Pathophysiological and Pharmacological Rationale for the Use of Exenatide Once Weekly in Patients with Type 2 Diabetes
por: Grossman, Samuel S.
Publicado: (2014)

Exenatide Treatment for 6 Months Improves Insulin Sensitivity in Adults With Type 1 Diabetes
por: Sarkar, Gayatri, et al.
Publicado: (2014)

Exenatide extended-release: a once weekly treatment for patients with type 2 diabetes
por: Mann, Katherine V, et al.
Publicado: (2014)

Clinical experience with exenatide in obese North Indian patients with type 2 diabetes mellitus
por: Bawa, Tarunika, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_npn4jrkugi744tslabn9h5avfr